Skp2 suppresses apoptosis in Rb1-deficient tumours by limiting E2F1 activity

Nature Communications

Volumn 5, Issue , 2014, Pages

  Lu, Zhonglei ^a   Bauzon, Frederick ^a   Fu, Hao ^a   Cui, Jinhua ^a   Zhao, Hongling ^a   Nakayama, Keiko ^b   Nakayama, Keiich I ^c   Zhu, Liang ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 7; CASPASE 9; CYCLIN A; CYCLIN E; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MINICHROMOSOME MAINTENANCE PROTEIN 3; PROTEIN P27; RETINOBLASTOMA PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2; TRANSCRIPTION FACTOR E2F1; UBIQUITIN PROTEIN LIGASE;

APOPTOSIS; BIOCHEMISTRY; CHEMICAL BINDING; CYTOLOGY; DEVELOPMENTAL BIOLOGY; ENZYME ACTIVITY; FUNCTIONAL ROLE; GENE EXPRESSION; MUTATION; TUMOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA CONTENT; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; GENE DELETION; GENE EXPRESSION; GENE MUTATION; MOUSE; NICK END LABELING; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; DOWN-REGULATION; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE, KNOCKOUT; NEOPLASMS; PITUITARY GLAND; RETINOBLASTOMA PROTEIN; S-PHASE KINASE-ASSOCIATED PROTEINS;

EID: 84896508118     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4463     Document Type: Article

References (62)

1. Burkhart, D. L. & Sage, J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat. Rev. Cancer 8, 671-682 (2008).
2. Chinnam, M. & Goodrich, D. W. RB1, development, and cancer. Curr. Top. Dev. Biol. 94, 129-169 (2011).
3. Yamasaki, L. et al. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice. Nat. Genet. 18, 360-364 (1998). (Pubitemid 28158165)
4. Ziebold, U., Lee, E. Y., Bronson, R. T. & Lees, J. A. E2F3 loss has opposing effects on different pRB-deficient tumors, resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas. Mol. Cell Biol. 23, 6542-6552 (2003). (Pubitemid 37075765)
5. Lee, E. Y. et al. E2F4 loss suppresses tumorigenesis in Rb mutant mice. Cancer Cell 2, 463-472 (2002). (Pubitemid 41043951)
6. Zhang, H., Kobayashi, R., Galaktionov, K. & Beach, D. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell 82, 915-925 (1995).
7. Bai, C. et al. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86, 263-274 (1996).
8. Frescas, D. & Pagano, M. Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat. Rev. Cancer 8, 438-449 (2008). (Pubitemid 351744963)
9. Zhang, L. & Wang, C. F-box protein Skp2: a novel transcriptional target of E2F. Oncogene 25, 2615-2627 (2005).
10. Yung, Y., Walker, J. L., Roberts, J. M. & Assoian, R. K. A Skp2 autoinduction loop and restriction point control. J. Cell Biol. 178, 741-747 (2007). (Pubitemid 47347359)
11. Binne, U. K. et al. Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit. Nat. Cell Biol. 9, 225-232 (2007). (Pubitemid 46420866)
12. Ji, P. et al. An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant. Mol. Cell 16, 47-58 (2004). (Pubitemid 39330151)
13. Wang, H. et al. Skp2 is required for survival of aberrantly proliferating Rb1- deficient cells and for tumorigenesis in Rb1+/- mice. Nat. Genet. 42, 83-88 (2010).
14. Korenjak, M. & Dyson, N. A vanishing act, explained. Dev. Cell 15, 793-794 (2008).
15. Krek, W. et al. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78, 161-172 (1994). (Pubitemid 24228310)
16. Krek, W., Xu, G. & Livingston, D. M. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 83, 1149-1158 (1995). (Pubitemid 26007806)
17. Dynlacht, B. D., Flores, O., Lees, J. A. & Harlow, E. Differential regulation of E2F trans-activation by cyclin-cdk2 complexes. Genes Dev. 8, 1772-1786 (1994). (Pubitemid 24265784)
18. Xu, M., Sheppard, K. A., Peng, C. Y., Yee, A. S. & Piwnica-Worms, H. Cyclin A/ CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/ DP-1 by phosphorylation. Mol. Cell Biol. 14, 8420-8431 (1994). (Pubitemid 24373591)
19. Marti, A., Wirbelauer, C., Scheffner, M. & Krek, W. Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat. Cell Biol. 1, 14-19 (1999). (Pubitemid 129495004)
20. Heriche, J. K., Ang, D., Bier, E. & O'Farrell, P. H. Involvement of an SCFSlmb complex in timely elimination of E2F upon initiation of DNA replication in Drosophila. BMC Genet. 4, 9 (2003).
21. Shibutani, S. T. et al. Intrinsic negative cell cycle regulation provided by PIP box- and Cul4Cdt2-mediated destruction of E2f1 during S phase. Dev. Cell 15, 890-900 (2008).
22. Nakayama, K. et al. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J. 19, 2069-2081 (2000). (Pubitemid 30237582)
23. Sage, J., Miller, A. L., Perez-Mancera, P. A., Wysocki, J. M. & Jacks, T. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424, 223-228 (2003). (Pubitemid 36858693)
24. Classon, M. & Harlow, E. The retinoblastoma tumour suppressor in development and cancer. Nat. Rev. Cancer 2, 910-917 (2002). (Pubitemid 37328892)
25. Vousden, K. H. Activation of the p53 tumor suppressor protein. Biochim Biophys. Acta 1602, 47-59 2002. (Pubitemid 34311899)
26. Irwin, M. et al. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 407, 645-648 (2000).
27. Stiewe, T. & Putzer, B. M. Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat. Genet. 26, 464-469 (2000).
28. DeGregori, J., Leone, G., Miron, A., Jakoi, L. & Nevins, J. R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl Acad. Sci. USA 94, 7245-7250 (1997). (Pubitemid 27345300)
29. Lazzerini Denchi, E. & Helin, K. E2F1 is crucial for E2F-dependent apoptosis. EMBO Rep. 6, 661-668 (2005).
30. Ziebold, U., Reza, T., Caron, A. & Lees, J. A. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev. 15, 386-391 (2001). (Pubitemid 32186999)
31. Trimarchi, J. M. & Lees, J. A. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol. 3, 11-20 (2002). (Pubitemid 135709914)
32. Chen, D., Chen, Y., Forrest, D. & Bremner, R. E2f2 induces cone photoreceptor apoptosis independent of E2f1 and E2f3. Cell Death Differ. 20, 931-940 (2013).
33. Yeh, K. H. et al. The F-box protein SKP2 binds to the phosphorylated threonine 380 in cyclin E and regulates ubiquitin-dependent degradation of cyclin E. Biochem. Biophys. Res. Commun. 281, 884-890 (2001).
34. Rossi, M. et al. The ubiquitin-protein ligase Itch regulates p73 stability. EMBO J. 24, 836-848 (2005). (Pubitemid 40396112)
35. Wu, L., Zhu, H., Nie, L. & Maki, C. G. A link between p73 transcriptional activity and p73 degradation. Oncogene 23, 4032-4036 (2004). (Pubitemid 38747932)
36. Zhao, H. et al. Skp2 deletion unmasks a p27 safeguard that blocks tumorigenesis in the absence of pRb and p53 tumor suppressors. Cancer Cell 24, 645-659 (2013).
37. Takahashi, Y., Rayman, J. B. & Dynlacht, B. D. Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev. 14, 804-816 (2000). (Pubitemid 30215000)
38. Wells, J., Boyd, K. E., Fry, C. J., Bartley, S. M. & Farnham, P. J. Target gene specificity of E2F and pocket protein family members in living cells. Mol. Cell Biol. 20, 5797-5807 (2000). (Pubitemid 30613029)
39. Zhu, L., Harlow, E. & Dynlacht, B. D. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev. 9, 1740-1752 (1995).
40. Adams, P. D. et al. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol. Cell Biol. 16, 6623-6633 (1996). (Pubitemid 26389720)
41. Besson, A. et al. Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype. Genes Dev. 21, 1731-1746 (2007). (Pubitemid 47076473)
42. Ji, P. et al. Skp2 contains a novel cyclin A binding domain that directly protects cyclin A from inhibition by p27Kip1. J. Biol. Chem. 281, 24058-24069 (2006). (Pubitemid 44274179)
43. Wei, W. et al. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 428, 194-198 (2004). (Pubitemid 38374317)
44. Bashir, T., Dorrello, N. V., Amador, V., Guardavaccaro, D. & Pagano, M. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature 428, 190-193 (2004). (Pubitemid 38374316)
45. Gao, D. et al. Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction. Nat. Cell Biol. 11, 397-408 (2009).
46. Morris, E. J. & Dyson, N. J. Retinoblastoma protein partners. Adv. Cancer Res. 82, 1-54 (2001). (Pubitemid 32613381)
47. Nicolay, B. N. et al. Loss of RBF1 changes glutamine catabolism. Genes Dev. 27, 182-196 (2013).
48. Lasorella, A., Rothschild, G., Yokota, Y., Russell, R. G. & Iavarone, A. Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice. Mol. Cell Biol. 25, 3563-3574 (2005). (Pubitemid 40559563)
49. Takahashi, C., Contreras, B., Bronson, R. T., Loda, M. & Ewen, M. E. Genetic interaction between Rb and K-ras in the control of differentiation and tumor suppression. Mol. Cell Biol. 24, 10406-10415 (2004). (Pubitemid 39507877)
50. Takahashi, C. et al. Nras loss induces metastatic conversion of Rb1-deficient neuroendocrine thyroid tumor. Nat. Genet. 38, 118-123 (2006). (Pubitemid 43011892)
51. Lin, W. et al. Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1. Proc. Natl Acad. Sci. USA 108, 13379-13386 (2011).
52. Lowe, S. W., Cepero, E. & Evan, G. Intrinsic tumour suppression. Nature 432, 307-315 (2004). (Pubitemid 39551658)
53. Hallstrom, T. C., Mori, S. & Nevins, J. R. An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell 13, 11-22 (2008). (Pubitemid 350309738)
54. Hallstrom, T. C. & Nevins, J. R. Specificity in the activation and control of transcription factor E2F-dependent apoptosis. Proc. Natl Acad. Sci. USA 100, 10848-10853 (2003). (Pubitemid 37140116)
55. Chan, C. H. et al. The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis. Cell 149, 1098-1111 (2012).
56. Lu, Z. et al. pRb is an obesity suppressor in hypothalamus and high-fat diet inhibits pRb in this location. EMBO J. 32, 844-857 (2013).
57. Kitagawa, M., Lee, S. H. & McCormick, F. Skp2 suppresses p53-dependent apoptosis by inhibiting p300. Mol. Cell 29, 217-231 (2008). (Pubitemid 351172826)
58. Balthasar, N. et al. Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 42, 983-891 (2004).
59. Malek, N. P. et al. A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase. Nature 413, 323-327 (2001). (Pubitemid 32905854)
60. Yamasaki, L. et al. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85, 537-548 (1996). (Pubitemid 26157192)
61. Sun, H., Gulbagci, N. T. & Taneja, R. Analysis of growth properties and cell cycle regulation using mouse embryonic fibroblast cells. Methods Mol. Biol. 383, 311-319 (2007).
62. Sun, D., Melegari, M., Sridhar, S., Rogler, C. E. & Zhu, L. A multi-miRNA hairpin method that improves gene knockdown efficiency and provides linked multi-gene knockdown. Biotechniques 41, 59-63 (2006). (Pubitemid 46534903)